Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors

Keyphrases

• Personalized Treatment 100%
• Genomic Profiling 100%
• Guided Therapy 100%
• CNS Tumors 100%
• Treatment Recommendations 66%
• Molecular Profiling 66%
• Adult Patients 33%
• Molecular Diagnostics 33%
• Germany 33%
• Freiburg 33%
• Tumor Subtype 33%
• Brain Tumor 33%
• Overall Response Rate 33%
• Targeted Treatment 33%
• Molecular Classification 33%
• Genetic Profile 33%
• Progression-free Survival 33%
• Disease Control Rate 33%
• MTOR Pathway 33%
• Molecular Tumor Board 33%
• Primary Brain Tumor 33%
• Brain Cancer 33%
• Cell Cycle Pathway 33%
• Clinical Outcomes 33%
• Primary Brain Cancer 33%
• Biomarker-guided Therapy 33%

Medicine and Dentistry

• Biological Marker 100%
• Molecular Profiling 100%
• Intracranial Tumor 100%
• Brain Cancer 100%
• Central Nervous System Tumor 100%
• Neoplasm 50%
• Progression Free Survival 50%
• Targeted Therapy 50%
• Cell Cycle 50%
• Mammalian Target of Rapamycin 50%
• Molecular Diagnostics 50%
• Diseases 50%

Biochemistry, Genetics and Molecular Biology

• Genetics 100%
• Mammalian Target of Rapamycin 50%
• Cell Cycle 50%
• Progression Free Survival 50%